Allen W - Search Results

1

Identification of 5-fluorouracil-inducible target genes using cDNA microarray profiling.

Maxwell PJ, Longley DB, Latif T, Boyer J, Allen W, Lynch M, McDermott U, Harkin DP, Allegra CJ, Johnston PG. Maxwell PJ, et al. Among authors: allen w. Cancer Res. 2003 Aug 1;63(15):4602-6. Cancer Res. 2003. PMID: 12907638

2

The roles of thymidylate synthase and p53 in regulating Fas-mediated apoptosis in response to antimetabolites.

Longley DB, Allen WL, McDermott U, Wilson TR, Latif T, Boyer J, Lynch M, Johnston PG. Longley DB, et al. Clin Cancer Res. 2004 May 15;10(10):3562-71. doi: 10.1158/1078-0432.CCR-03-0532. Clin Cancer Res. 2004. PMID: 15161716

3

Effect of p53 status and STAT1 on chemotherapy-induced, Fas-mediated apoptosis in colorectal cancer.

McDermott U, Longley DB, Galligan L, Allen W, Wilson T, Johnston PG. McDermott U, et al. Among authors: allen w. Cancer Res. 2005 Oct 1;65(19):8951-60. doi: 10.1158/0008-5472.CAN-05-0961. Cancer Res. 2005. PMID: 16204068

4

The role of thymidylate synthase induction in modulating p53-regulated gene expression in response to 5-fluorouracil and antifolates.

Longley DB, Boyer J, Allen WL, Latif T, Ferguson PR, Maxwell PJ, McDermott U, Lynch M, Harkin DP, Johnston PG. Longley DB, et al. Cancer Res. 2002 May 1;62(9):2644-9. Cancer Res. 2002. PMID: 11980662

5

The interaction of thymidylate synthase expression with p53-regulated signaling pathways in tumor cells.

Longley DB, Latif T, Boyer J, Allen WL, Maxwell PJ, Johnston PG. Longley DB, et al. Semin Oncol. 2003 Jun;30(3 Suppl 6):3-9. doi: 10.1016/s0093-7754(03)00119-2. Semin Oncol. 2003. PMID: 12802789

6

Role of genomic markers in colorectal cancer treatment.

Allen WL, Johnston PG. Allen WL, et al. J Clin Oncol. 2005 Jul 10;23(20):4545-52. doi: 10.1200/JCO.2005.19.752. J Clin Oncol. 2005. PMID: 16002846 Review.

7

Have we made progress in pharmacogenomics? The implementation of molecular markers in colon cancer.

Allen WL, Johnston PG. Allen WL, et al. Pharmacogenomics. 2005 Sep;6(6):603-14. doi: 10.2217/14622416.6.6.603. Pharmacogenomics. 2005. PMID: 16143000 Review.

8

Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer.

Boyer J, Allen WL, McLean EG, Wilson PM, McCulla A, Moore S, Longley DB, Caldas C, Johnston PG. Boyer J, et al. Cancer Res. 2006 Mar 1;66(5):2765-77. doi: 10.1158/0008-5472.CAN-05-2693. Cancer Res. 2006. PMID: 16510598

9

Drug resistance, predictive markers and pharmacogenomics in colorectal cancer.

Longley DB, Allen WL, Johnston PG. Longley DB, et al. Biochim Biophys Acta. 2006 Dec;1766(2):184-96. doi: 10.1016/j.bbcan.2006.08.001. Epub 2006 Aug 9. Biochim Biophys Acta. 2006. PMID: 16973289 Review.

10

The role of spermidine/spermine N1-acetyltransferase in determining response to chemotherapeutic agents in colorectal cancer cells.

Allen WL, McLean EG, Boyer J, McCulla A, Wilson PM, Coyle V, Longley DB, Casero RA Jr, Johnston PG. Allen WL, et al. Mol Cancer Ther. 2007 Jan;6(1):128-37. doi: 10.1158/1535-7163.MCT-06-0303. Mol Cancer Ther. 2007. PMID: 17237273

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,409 results

Search Page

Filters